Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01618253
Recruitment Status : Withdrawn (Closed due to poor accrual.)
First Posted : June 13, 2012
Last Update Posted : September 5, 2013
Information provided by (Responsible Party):
Medical College of Wisconsin